ÂÜÀòÂÒÂ×

Marcin Goszyk is a seasoned professional in the fields of private equity and healthcare. Currently serving as a Principal at ARCHIMED since June 2020, Marcin also holds Board Director positions at Groupe CARSO and NAMSA, where oversight focuses on analytical services and medical device research, respectively. Marcin's previous roles include Investment Director at Corviglia Capital Fund and Innova Capital, and Principal at The Riverside Company, showcasing expertise in tech investments and growth-focused private equity. Academic credentials include a Global Executive MBA from INSEAD and ongoing studies in Biotechnology at MIT, complemented by training in fintech and coaching. Marcin's educational foundation is further strengthened by a Master of Science in Finance from Wroclaw University of Economics and Business.